All In Biotech

Free tool

FAERS Monitor: Verzenio

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 208855 or its brand name (Verzenio, Abemaciclib). Reports on generic versions are filed under their own applications.

Reports

21,145

Serious

10,932

52% of reports

Hospitalization

4,417

Death reported

1,481

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • diarrhoea6,577
  • fatigue2,834
  • nausea2,345
  • vomiting1,196
  • malignant neoplasm progression1,148
  • decreased appetite1,021
  • asthenia941
  • death811
  • constipation767
  • white blood cell count decreased761
  • drug ineffective752
  • abdominal pain upper735
  • anaemia729
  • neutropenia687
  • off label use664

Reports by year received

View as table
YearReports
20142
20154
20164
201725
2018850
20191,657
20201,648
20211,496
20222,192
20232,788
20243,399
20253,735
20263,345

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,033,014 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
malignant neoplasm progressionSignal1,14811.310.610,660
diarrhoeaSignal6,57710.210.055,914
white blood cell count decreasedSignal7617.06.63,919
neutropeniaSignal6875.04.72,228
decreased appetiteSignal1,0214.44.12,685
anaemiaSignal7293.83.51,518
fatigueSignal2,8343.63.55,586
abdominal pain upperSignal7353.63.31,359
constipationSignal7673.53.31,382
nauseaSignal2,3453.02.83,136
vomitingSignal1,1962.52.41,132
astheniaSignal9412.52.3853
death8110.90.94
off label use6640.80.755
drug ineffective7520.60.5264

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.